Agreed,
I can't deny it, there is more risk compared to a year ago from the funding side....and yes, it's getting a little too close to the flame...I doubt we will have funds to last till the end of the P3....BUT, despite that, I know there are viable alternatives to another round of dilutive CR...in fact I'm pretty confident we won't be having another of those any time soon! Let's avoid that oblivion type scenario.
I'll have more to say about it on the weekend...
Just catching up on some work but will post more soon.
Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial, page-23
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $261.4K | 990.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 9445 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |